Entero Healthcare Acquires 51.5% Stake in Anand Chemiceutics, A Leading Diagnostic and MedTech Solutions Provider

Entero Healthcare Solutions Limited, a leading and fastest-growing distributor of healthcare products, has successfully closed the acquisition of Anand Chemiceutics Private Limited, an industry-leading distributor of diagnostic products and preferred channel partner for global diagnostic and MedTech product companies. The acquisition strengthens Entero’s position in the fast-growing MedTech segment, creating opportunities for leveraging collective distribution strength, partnership, geographical reach, and expertise. Anand Chemiceutics has a strong pan-India presence and customer service network of more than 1,500 laboratories, hospitals, and government institutions. It is also a leading turnkey solutions provider for hospitals and laboratories. With this acquisition, Entero Healthcare expects the MedTech segment to contribute more than INR 1,000 Cr in annualised revenue in the next financial year.